Home › Schizophrenia › Illinois › Chicago
Pag-aaral pangklinika para sa Schizophrenia sa Chicago, IL
Isang pag-aaral para sa Schizophrenia ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Chicago. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
Nagre-recruitPhase 3
- EmVenio Research Center - Prime Healthcare, Chicago
A Study to Evaluate the Effect of KarXT on Urological Safety
Nagre-recruitPhase 4
- Uptown Research Institute, Chicago
- Pillar Clinical Research -Chicago, Chicago
Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- The University of Chicago, Chicago
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
Nagre-recruitPhase 3
- EmVenio Research Center - Prime Healthcare, Chicago
A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
Nagre-recruitPhase 1
- Uptown Research Institute, Chicago
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
Nagre-recruitPhase 3
- Local Institution - 0067, Chicago
- Pillar Clinical Research -Chicago, Chicago
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
Nagre-recruitPhase 2
- Clinical Site, Chicago
A Study of Brenipatide in Adult Participants With Schizophrenia
Nagre-recruitPhase 2
- Re:Cognition Health - Chicago, Chicago
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
Nagre-recruitPhase 3
- Neurocrine Clinical Site, Chicago
52-week Open Label Safety-Tolerability Study
Nagre-recruitPhase 3
- Pillar Clinical Research, Chicago
A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
Nagre-recruitPhase 1
- Uptown Research Institute, Chicago
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
Nagre-recruitPhase 3
- Alkermes Investigator Site, Chicago
Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
Nagre-recruitPhase 2
- Uptown Research Institute LLC, Chicago
- Pillar Clinical Research LLC, Chicago
Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
Nagre-recruitPhase 3
- Pillar Clinical Research, Chicago
CLOZAPINE Response in Biotype-1
Nagre-recruitPhase 4
- University of Chicago, Chicago
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
Nagre-recruitObservasyonal na pag-aaral
- University of Chicago Medical Center, Chicago
NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Nagre-recruitPhase 3
- Neurocrine Clinical Site, Chicago
Randomized Withdrawal Study in Patients With Schizophrenia
Nagre-recruitPhase 3
- Vanda Investigational Site, Chicago
Study of ALTO-101 in Patients With Schizophrenia
Nagre-recruitPhase 2
- Site 5056, Chicago
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo
- Reviva site, Chicago
Pag-aaral para sa Schizophrenia sa ibang lungsod
- Atlanta, GA21 pag-aaral
- Little Rock, AR18 pag-aaral
- San Diego, CA15 pag-aaral
- Houston, TX14 pag-aaral
- Boston, MA14 pag-aaral
- Hollywood, FL14 pag-aaral
- Hialeah, FL13 pag-aaral
- Austin, TX12 pag-aaral
- Garden Grove, CA12 pag-aaral
- New York City, NY12 pag-aaral
- Miami, FL10 pag-aaral
- Germantown, MD10 pag-aaral
Iba pang pag-aaral sa Chicago
- Kanser sa Suso59 pag-aaral
- Non-Small Cell Lung Cancer59 pag-aaral
- Kanser (lahat ng uri)51 pag-aaral
- Kanser sa Prostate45 pag-aaral
- Kanser sa Baga43 pag-aaral
- Metastatic Cancer42 pag-aaral
- Obesity40 pag-aaral
- Kanser sa Ovary36 pag-aaral
- Colorectal Cancer32 pag-aaral
- Stroke31 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg29 pag-aaral
- Overweight29 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.